These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24854541)

  • 41. Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro.
    Aldonyte R; Jansson L; Janciauskiene S
    BMC Cell Biol; 2004 Mar; 5():11. PubMed ID: 15050036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid renal alpha-1 antitrypsin gene induction in experimental and clinical acute kidney injury.
    Zager RA; Johnson AC; Frostad KB
    PLoS One; 2014; 9(5):e98380. PubMed ID: 24848503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex-specific differences in emphysema using a murine antisense oligonucleotide model of α-1 antitrypsin deficiency.
    Joshi R; Ojha M; Lewis J; Fan Q; Monia B; Guo S; Varisco BM
    Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1165-L1173. PubMed ID: 31017014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha-1-antitrypsin inhibits nitric oxide production.
    Chan ED; Pott GB; Silkoff PE; Ralston AH; Bryan CL; Shapiro L
    J Leukoc Biol; 2012 Dec; 92(6):1251-60. PubMed ID: 22975343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.
    Hawkins P; Sya J; Hup NK; Murphy MP; McElvaney NG; Reeves EP
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441020
    [No Abstract]   [Full Text] [Related]  

  • 46. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin.
    Shen L; Dahlbäck B; Villoutreix BO
    Biochemistry; 2000 Mar; 39(11):2853-60. PubMed ID: 10715104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of noninhibitory alpha-1-antitrypsin on primary human monocyte activation in vitro.
    Moraga F; Lindgren S; Janciaskiene S
    Arch Biochem Biophys; 2001 Feb; 386(2):221-6. PubMed ID: 11368345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release.
    Nita I; Hollander C; Westin U; Janciauskiene SM
    Respir Res; 2005 Jan; 6(1):12. PubMed ID: 15683545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beyond the lungs: Alpha-1 antitrypsin's potential role in human gestation.
    Jezela-Stanek A; Chorostowska-Wynimko J
    Adv Clin Exp Med; 2019 Sep; 28(9):1257-1261. PubMed ID: 30929319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preservation with α
    Götzfried J; Smirnova NF; Morrone C; Korkmaz B; Yildirim AÖ; Eickelberg O; Jenne DE
    J Heart Lung Transplant; 2018 Aug; 37(8):1021-1028. PubMed ID: 29776812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
    Ortiz G; Salica JP; Chuluyan EH; Gallo JE
    Biol Res; 2014 Nov; 47():58. PubMed ID: 25723058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. alpha1-Antitrypsin deficiency: best clinical practice.
    Kalsheker NA
    J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo.
    Subramaniyam D; Steele C; Köhnlein T; Welte T; Grip O; Matalon S; Janciauskiene S
    Inflamm Res; 2010 Jul; 59(7):571-8. PubMed ID: 20238140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin.
    Sosulski ML; Stiles KM; Frenk EZ; Hart FM; Matsumura Y; De BP; Kaminsky SM; Crystal RG
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In Vivo Analysis of Alpha-1-Antitrypsin Functions in Autoimmune Disease Models.
    Song S; Lu Y; Elshikha AS
    Methods Mol Biol; 2018; 1826():143-155. PubMed ID: 30194599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic elastase inhibition by alpha-1-antitrypsin gene transfer limits neointima formation in normal rabbits.
    Waugh JM; Li-Hawkins J; Yuksel E; Cifra PN; Amabile PG; Hilfiker PR; Geske RS; Kuo MD; Thomas JW; Dake MD; Woo SL
    J Vasc Interv Radiol; 2001 Oct; 12(10):1203-9. PubMed ID: 11585887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The discovery of α1-antitrypsin and its role in health and disease.
    Janciauskiene SM; Bals R; Koczulla R; Vogelmeier C; Köhnlein T; Welte T
    Respir Med; 2011 Aug; 105(8):1129-39. PubMed ID: 21367592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial.
    Campos MA; Geraghty P; Holt G; Mendes E; Newby PR; Ma S; Luna-Diaz LV; Turino GM; Stockley RA
    Am J Respir Crit Care Med; 2019 Aug; 200(3):318-326. PubMed ID: 30965011
    [No Abstract]   [Full Text] [Related]  

  • 60. TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin.
    Subramaniyam D; Virtala R; Pawłowski K; Clausen IG; Warkentin S; Stevens T; Janciauskiene S
    Int J Biochem Cell Biol; 2008; 40(2):258-71. PubMed ID: 17869162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.